Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKD 0.34
(-6.94%)
HKD 0.34
(-6.94%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 66.86 Million CNY | -45.02% |
| 2022 | 124.33 Million CNY | 8.79% |
| 2021 | 114.29 Million CNY | 25.98% |
| 2020 | 90.72 Million CNY | 39.03% |
| 2019 | 65.25 Million CNY | 1.16% |
| 2018 | 64.5 Million CNY | 79.95% |
| 2017 | 35.84 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | 46.47 Million HKD | 0.0% |
| 2023 FY | 68.36 Million CNY | -45.02% |
| 2023 Q4 | 29.46 Million HKD | 0.0% |
| 2022 FY | 124.33 Million CNY | 8.79% |
| 2022 Q4 | 69.39 Million HKD | 0.0% |
| 2022 Q2 | 81.2 Million HKD | 0.0% |
| 2021 Q2 | 72.04 Million HKD | 0.0% |
| 2021 FY | 114.29 Million CNY | 25.98% |
| 2021 Q4 | 64.87 Million HKD | 0.0% |
| 2020 Q4 | 17.66 Million CNY | -2.61% |
| 2020 Q3 | 18.14 Million CNY | 0.0% |
| 2020 FY | 90.72 Million CNY | 39.03% |
| 2019 Q4 | 8.62 Million CNY | 0.0% |
| 2019 FY | 65.25 Million CNY | 1.16% |
| 2018 FY | 64.5 Million CNY | 79.95% |
| 2017 FY | 35.84 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 7.68 Billion HKD | 99.129% |